Emergent Biosolutions
EBS
EBS
254 hedge funds and large institutions have $1.81B invested in Emergent Biosolutions in 2021 Q4 according to their latest regulatory filings, with 47 funds opening new positions, 88 increasing their positions, 94 reducing their positions, and 68 closing their positions.
Holders
254
Holders Change
-22
Holders Change %
-7.97%
% of All Funds
3.92%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
47
Increased
88
Reduced
94
Closed
68
Calls
$6.65M
Puts
$6.48M
Net Calls
+$161K
Net Calls Change
+$70K
Top Buyers
| 1 |
1
BlackRock
New York
|
$351M |
| 2 |
2
D.E. Shaw & Co
New York
|
$41.1M |
| 3 |
3
State Street
Boston,
Massachusetts
|
$132M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$233M |
| 5 |
5
Millennium Management
New York
|
$17.4M |
